Camber Pharmaceuticals Accelerates Copay Card Program

Camber Pharmaceuticals is pleased to announce it has recently added 4 products to its’ Copay Card Program, which will save patients a substantial amount of money each year. The products include:

  • Deferasirox tablets
  • Dimethyl Fumarate capsules
  • Droxidopa capsules
  • Vigabatrin oral solution

“Camber’s Copay Card Program is designed to help patients by increasing access to affordable medicines and improving health outcomes” stated Kon Ostaficiuk, President of Camber.

Numerous studies have shown prescription copayments are a major incentive to drug adherence. In some cases, patients never fill prescriptions or ration medicine or doses to save money.

“Adding these prescriptions to a copay plan makes Camber’s products very attractive to patients and retailers alike. With many prescription drug insurance plans, the patient could have little-to-no copayment,” Kon added.“We hope this brings financial relief to more patients and encourages them follow their healthcare provider’s advice.”

Product Descriptions

Camber Pharmaceuticals is a fully integrated international pharmaceutical company that maintains quality and integrity in all its products. Its parent company, Hetero Drugs of Hyderabad India, is one of the world’s leading API and finished dosage manufacturers. Camber’s commitment to the consumer is to bring the highest quality generic pharmaceuticals to the market to improve quality of life through cost-effective medications.

SOURCE: Camber Pharmaceuticals